Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study
Muhammad Khan,1,2 Zhihong Zhao,3 Xianming Li,1 Guixiang Liao1 1Department of Oncology, Shenzhen People’s Hospital, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, People’s Republic of China; 2Department of Oncology, First Affiliated Hospital of Anhui Medical Uni...
Enregistré dans:
| Auteurs principaux: | Khan M, Zhao Z, Li X, Liao G |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/7c9493d3c20f46c188856410c2c514ec |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Reirradiation of Whole Brain for Recurrent Brain Metastases: A Case Report of Lung Cancer With 12-Year Survival
par: Minmin Li, et autres
Publié: (2021) -
Predictive effect of DCE-MRI and DWI in brain metastases from NSCLC
par: Ye Chengyu, et autres
Publié: (2021) -
An Agent-Based Model of Combination Oncolytic Viral Therapy and Anti-PD-1 Immunotherapy Reveals the Importance of Spatial Location When Treating Glioblastoma
par: Kathleen M. Storey, et autres
Publié: (2021) -
Topical Medication Therapy for Glaucoma and Ocular Hypertension
par: Tao Wang, et autres
Publié: (2021) -
Response and safety of whole‐brain radiotherapy plus temozolomide for patients with brain metastases of non‐small‐cell lung cancer: A meta‐analysis
par: Jianguo Han, et autres
Publié: (2021)